May 29, 2019 | News
Healix Infusion Therapy Selected as Limited Distribution Network Partner for Cutaquig®, Octapharma’s new 16.5% Subcutaneous Immune Globulin. SUGAR LAND, TX ( May 29, 2019) – Healix Infusion Therapy is pleased to announce that it has been selected as a limited...
Feb 25, 2019 | News
Healix, the nation’s leader in providing physician office-based infusion services, will implement the Citus Health digital solution suite to streamline multi-office healthcare communications and automate documentation workflows to provide the highest-quality patient...
Dec 6, 2018 | News
SUGAR LAND, TX (December 6, 2018) – Healix, the nation’s leader in providing physician office-based infusion services, announces a strategic partnership with WeInfuse, the first and only end-to-end workflow software application purpose-built for infusion...
Jul 20, 2018 | News
SUGAR LAND, TX (July 20, 2018) – Healix, the nation’s leader in physician office based infusion services, announced a strategic relationship with DoseMe, a precision dosing decision support platform specifically for clinical practice. “We are really pleased to partner...
Dec 18, 2017 | News
BOSTON and SUGAR LAND, Texas, December 18, 2017 – TA Associates, a leading global growth private equity firm, today announced that it has completed a strategic growth investment in Healix, a provider of outsourced alternate-site infusion therapy management services....
Jul 28, 2017 | News
SUGAR LAND, TX (July 28, 2017) – Healix Infusion Therapy, Inc. is proud to announce the relocation of its pharmacy operation to a new, state-of-the-art facility in Sugar Land, Texas. With more than 28 years of sterile compounding services, the Healix Infusion Therapy...
Recent Comments